Chronic obstructive pulmonary disease
![Sanofi, Special care, Bill Sibold, chronic obstructive pulmonary disease](https://pharmtales.com/wp-content/uploads/2023/08/Sanofis-specialty-care-chief-Sibold-leaves-amid-executive-reshuffle.jpg)
Sanofiās specialty care chief Sibold leaves amid executive reshuffle
Anika Sharma
After an impressive six-year tenure steering Sanofi’s specialty care division, Bill Sibold is bidding adieu to embrace a new external ...
![Verona Pharma has recently filed a New Drug Application to FDA for the use of ensifentrine as a maintenance treatment for chronic obstructive pulmonary disease](https://pharmtales.com/wp-content/uploads/2023/06/Verona-Pharma-has-recently-filed-a-New-Drug-Application-to-FDA-for-the-use-of-ensifentrine-as-a-maintenance-treatment-for-chronic-obstructive-pulmonary-disease-Cat_-latest-News-Pharma.jpg)
Verona Pharma has recently filed a New Drug Application to FDA for the use of ensifentrine as a maintenance treatment for chronic obstructive pulmonary disease
SG Tylor
Source – Verona Pharma On June 27, 2023, Verona Pharma announced the submission of a New Drug Application (NDA) to ...